zipjet
58.9K posts

zipjet
@zipjet
Investor, econ wonk, Acct Prof., Lawyer, xCEO, Biotechs John 3:16 "Likes" not agree. LTBH & trading, Options. LQDA,OCUL,TGTX,HROW,ORCL,AMZN,ARLP,NFLX,GOOG



⁉️ Who is surprised? Are you surprised? ⁉️

It's kind of hilarious how the regime in Iran is firing missiles at the entire region EXCEPT for Israel, because they know Israel will simply kill them all if given a reason.

This BoA analyst on $TGTX is the most extreme examples of a biased analyst at a major IB that I have ever seen. He keeps raising long term revenue estimates, but always finds some excuse to maintain a price target dramatically below the stock price. Once upon a time it was the threat from the Ocrevus "subq" that of course never emerged. Now complaining about increased operating expenses even though the company has noted it is currently expensing an inventory build for subq that should serve to reduce COGS when it is finally launched.


This is the intellectual version of a COVID Mask. You may think you’re doing something smart but you’re not.

After 166 years, the Know Nothing Party has returned to US politics. They’ve switched parties too.




$TGTX For TG Therapeutics, BofA said the company's Q2 results "should again center on whether Briumvi can keep outpacing already-raised expectations." Also, TG Therapeutics' comments on operating expenses will be important after the company's Q1 results showed "meaningful sequential increases" in research and development as well as selling, general and administrative expenses, the note said. BofA increased its outer-year Briumvi estimates to "reflect greater franchise stability following recent updates." The investment firm raised TG Therapeutics' price objective to $20 from $17 and reiterated the company's Underperform rating.













